Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[The JAK2 mutation in myeloproliferative disorders: A predictive factor of thrombosis].

La Tunisie medicale - 1 Jul 2015

Mahjoub Sonia, Baccouche Héla, Sahnoun Mariam, Kaabi Houda, Manai Zeineb, Slama Hmida, Ben Romdhane Neila

Abstract excerpt

BACKGROUND: BCR-ABL negative myeloproliferative neoplasms (MPN) include polycythemia Vera (PV), essential thrombocythemia (ET) and primitive myelofibrosis (PMF). the JAK2 V617F mutation has been introduced since 2008 as a major diagnostic criterion on the one hand and on the other hand, it would be linked to increased risk of thrombotic complications. AIM: This study aimed to evaluate the association of JAK2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Thrombosis
Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Janus Kinase 2

Share to Mutation

Share to Myeloproliferative Disorders

Share to Risk Factors

Share to Young Adult

Source

Identifiers

PMID: 26757507

Genes

JAK2
BCR

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[The JAK2 mutation in myeloproliferative disorders: A predictive factor of thrombosis].PMID 26757507Read ↗

[Correlative study between JAK2 mutation and thrombosis in patients with myeloproliferative neoplasm].Semantic proximity Read ↗

JAK2 mutation-related disease and thrombosis.Semantic proximity Read ↗

[Thrombosis in myeloproliferative neoplasms].Semantic proximity Read ↗

[Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].Semantic proximity Read ↗

[Essential thrombocythemia. Contribution of the V617F JAK2 mutation to the pathophysiology, diagnosis and outcome].Semantic proximity Read ↗

JAK2 mutation and thrombosis in the myeloproliferative neoplasms.Semantic proximity Read ↗

Vascular events in Korean patients with myeloproliferative neoplasms and their relationship to JAK2 mutation.Semantic proximity Read ↗

Clinical significance of V617F mutation of the JAK2 gene in patients with chronic myeloproliferative disorders.Semantic proximity Read ↗

Molecular biomarkers of thrombosis in myeloproliferative neoplasms.Semantic proximity Read ↗

[Budd-Chiari syndrome and JAK2 gene mutation].Semantic proximity Read ↗

[Clinical significance of the quantification of JAK2V617F allele burden in classical Ph-negative myeloproliferative neoplasms].Semantic proximity Read ↗

[Detection and clinical significance of JAK2 mutation in 412 patients with chronic myeloproliferative neoplasms].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.